ArticleCancers2022

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management.

Ariane Hallermayr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.